Close
CDMO Safety Testing 2026
Novotech

Merck and Tridonic Enter Into License Agreement for White LEDs

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

- Advertisement -

Merck, a leading company for innovative and top-quality high-tech products in the healthcare, life science and performance materials sectors, announced today that it has entered into a license agreement with Tridonic Jennersdorf GmbH (Tridonic) covering silicate phosphors for use in white light LEDs.

Along with Toyoda Gosei Co. Ltd. (Japan), Leuchtstoffwerk Breitungen GmbH (Germany), and Litec GbR (Germany), Tridonic holds basic patents relating to a technology to generate white light using blue LEDs and novel yellow silicate phosphors. This combination of silicate phosphors applied to blue LED chips enable manufacturing of packaged white LEDs with high accuracy and high brightness. Primary applications include backlights for cell phones, laptops, GPS and other small displays, which account for a high share of todayโ€™s global LED market.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems

Bristol Myers Squibb has entered into a strategic agreement...

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป